The Challenges of First-in-Human Stem Cell Clinical Trials: What Does This Mean for Ethics and Institutional Review Boards?
Stem cell-based clinical interventions are increasingly advancing through preclinical testing and approaching clinical trials. The complexity and diversity of these approaches, and the confusion created by unproven and untested stem cell-based “therapies,” create a growing need for a more comprehens...
Main Authors: | Roger A. Barker, Melissa K. Carpenter, Stuart Forbes, Steven A. Goldman, Catriona Jamieson, Charles E. Murry, Jun Takahashi, Gordon Weir |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-05-01
|
Series: | Stem Cell Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213671118301784 |
Similar Items
-
What does Finch mean for researchers, librarians and publishers?
by: Steven Hall
Published: (2012-11-01) -
What does it mean to be 'pro-arbitration'?
by: Bermann, G.A
Published: (2018) -
What Does Engineering Ethics Involve?
by: Andreea BAN, et al.
Published: (2018-12-01) -
What does it mean to be innovative?
by: Peter J Carrington, et al.
Published: (2016-03-01) -
What does ‘to enlighten’ mean?
by: Mendelssohn M.
Published: (2011-10-01)